CAPLIPOINT — Caplin Point Laboratories Balance Sheet
0.000.00%
- IN₹162.54bn
- IN₹153.35bn
- IN₹19.37bn
- 95
- 14
- 89
- 76
Annual balance sheet for Caplin Point Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4,675 | 5,087 | 6,436 | 7,807 | 9,601 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,867 | 4,371 | 5,626 | 7,368 | 6,325 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 10,358 | 12,978 | 15,545 | 18,929 | 21,340 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3,119 | 2,935 | 4,894 | 5,568 | 6,737 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 13,636 | 17,363 | 21,914 | 26,981 | 32,086 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,429 | 2,077 | 2,680 | 3,313 | 3,064 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,778 | 2,524 | 3,109 | 3,824 | 3,581 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 11,858 | 14,839 | 18,805 | 23,157 | 28,505 |
Total Liabilities & Shareholders' Equity | 13,636 | 17,363 | 21,914 | 26,981 | 32,086 |
Total Common Shares Outstanding |